NCT05042791 2024-02-09A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain MetastasesJiangxi Provincial Cancer HospitalPhase 2 Unknown362 enrolled
NCT04385563 2020-05-13A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 Unknown338 enrolled